We are a global leader specialising in all phases of diagnostic research from discovery, development and validation, and commercialisation with experts on staff to conduct research in the US, EU and Asia Pacific region.
Our diverse experience in this area provides our clients a level of comfort because we understand that these are not drug development studies. We understand the importance of clinical in-vitro diagnostic and biomarker research for the greater good of healthcare. Our central monitoring approach and comprehensive knowledge of the regulatory environments help to speed up study timelines, focus on patient outcomes and optimise your clinical sample quality.